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Abstract
Introduction: The Health Assessment Questionnaire Disability Index (HAQ) and the SF-36 PF-10, among other
instruments, yield sensitive and valid Disability (Physical Function) endpoints. Modern techniques, such as Item
Response Theory (IRT), now enable development of more precise instruments using improved items. The NIH
Patient Reported Outcomes Measurement Information System (PROMIS) is charged with developing improved IRT-
based tools. We compared the ability to detect change in physical function using original (Legacy) instruments
with Item-Improved and PROMIS IRT-based instruments.
Methods: We studied two Legacy (original) Physical Function/Disability instruments (HAQ, PF-10), their item-
improved derivatives (Item-Improved HAQ and PF-10), and the IRT-based PROMIS Physical Function 10- (PROMIS PF
10) and 20-item (PROMIS PF 20) instruments. We compared sensitivity to detect 12-month changes in physical
function in 451 rheumatoid arthritis (RA) patients and assessed relative responsiveness using P-values, effect sizes
(ES), and sample size requirements.
Results: The study sample was 81% female, 87% Caucasian, 65 years of age, had 14 years of education, and had
moderate baseline disability. All instruments were sensitive to detecting change (< 0.05) in physical function over
one year. The most responsive instruments in these patients were the Item-Improved HAQ and the PROMIS PF 20.
IRT-improved instruments could detect a 1.2% difference with 80% power, while reference instruments could
detect only a 2.3% difference (P < 0.01). The best IRT-based instruments required only one-quarter of the sample
sizes of the Legacy (PF-10) comparator (95 versus 427). The HAQ outperformed the PF-10 in more impaired
populations; the reverse was true in more normal populations. Considering especially the range of severity
measured, the PROMIS PF 20 appears the most responsive instrument.
Conclusions: Physical Function scales using item improved or IRT-based items can result in greater responsiveness
and precision across a broader range of physical function. This can reduce sample size requirements and thus
study costs.
Introduction
Successful management of chronic illnesses, such as
rheumatoid arthritis (RA), depends in part upon instru-
ments that validly and precisely measure Physical Func-
tion (PF) and can guide appropriate intervention. In RA,
Physical Function is commonly assessed by the Health
Assessment Questionnaire Disability Index (HAQ or
HAQ-DI) [1] and the SF-36 PF-10 [2], both developed
three decades ago using classical test theory. Conse-
quently, they were not subjected to modern psycho-
metric approaches, including study of domain
definitions, item context and difficulty, time frame,
response options, clarity, importance, or information
content. Modern methods, like Item Response Theory
(IRT), quantitatively assess item properties and identify
items with the highest information content [3,4],
enabling development of more precise instruments [4,5].
Improved instrument sensitivity can result from using
IRT-based item calibrations, selection of the best items
for new instruments, and using individually tailored
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tistical power or hold statistical power constant while
decreasing questionnaire burden [6,7].
The Patient Reported Outcome Measurement Infor-
mation System (PROMIS) is an NIH Roadmap infra-
structure project charged with developing IRT-based
patient reported outcome instruments for improved
validity and efficiency in experimental and observational
studies [8,9]. Physical Function is one of the initial PRO-
MIS health domains and is defined as “the ability to per-
form activities of daily living (ADL) and instrumental
activities of daily living” (IADL) [10]. It is analogous to
most existing instruments, including the original
(Legacy) HAQ [1,11] and PF-10 [2]. The term “Physical
Function” is favored by PROMIS over “Disability” [12],
since “Disability” refers only to decrements of function
below the population mean while “Physical Function”
includes abilities both above and below the mean. The
PROMIS conceptual framework includes Physical Func-
tion from functional loss to activity and participation
issues and is consistent with the WHO International
Classification of Function (ICF) model [13].
The 154-item PROMIS PF item bank was developed
using classic and modern item assessment methods
[12,14] and includes the 20-item stems of the original
HAQ and the 10-item stems of the original PF10. Physi-
cal Function items (n = 1,860) were aggregated from
exhaustive literature searches and evaluated for attri-
butes including clarity, importance and comprehension,
uni-dimensionality, independence, item difficulty, and
item information content and were calibrated on more
than 20,000 normal and diseased participants [4,12].
This study was designed to determine comparative
responsiveness and effects on sample size requirements
between Legacy, Item-Improved and PROMIS IRT-
b a s e di n s t r u m e n t s .W eh y p o t h e s i z e dt h a tt h em o d i f i e d
new instruments would be sensitive to change over 12
months, would assess responsiveness (sensitivity to
change) as well or better than Legacy instruments,
would be applicable to greater ranges of disease severity,
and would require smaller sample sizes than Legacy
instruments.
Materials and methods
Participants
English-speaking participants met American College of
Rheumatology criteria for RA. Of 521 participants com-
pleting initial questionnaires, we studied the 451 (87%)
who returned both baseline and 12-month question-
naires. Respondents were 81% female, 87% Caucasian,
averaged 65 years of age with 14 years of education, and
h a dab a s e l i n eL e g a c yH A Qs c o r ea v e r a g i n g0 . 8 8 .T h e
Stanford Institutional Review Board approved the study,
and all subjects gave written informed consent.
Instruments
We studied six instruments: the (1) Legacy HAQ and (2)
PF-10, (3) Item-Improved HAQ and (4) Item-Improved
PF-10, and the (5) PROMIS PF-10 and (6) PROMIS PF-
20. The Legacy HAQ and PF-10 ask about ability over
the past week. The Legacy HAQ contains 20 items in
eight categories (dressing and grooming, arising, eating,
walking, hygiene, reach, grip and activities) with four
response options: “without any difficulty,”“ with some
difficulty,”“ with much difficulty,”“ unable to do.” The
Legacy PF-10 contains 10 items with three response
options: “yes, limited a lot,”“ yes, limited a little,” and
“no, not limited at all”.
The IRT-based instruments, the Item-Improved 20-
item HAQ and 10-item PF-10 and the PROMIS PF-10
and PF-20 all assess present abilities (for example, Are
you able to walk a block?). Both “Item-Improved instru-
ments” have five-response options: HAQ - “without any
difficulty,”“ with a little difficulty,”“ with some difficulty,”
“with much difficulty,”“ unable to do"; PF-10 - “not at
all,”“ very little,”“ somewhat,”“ q u i t eal o t , ”“ cannot do.”
We term these items “improved” since PROMIS studies
document that present tense and a five-item response
set improve instrument responsiveness. Thus, the “item-
improved” instruments retain the stem of the original
items, but have “improved” the tense to “present” and
the response categories to “five” (together with minor
improvements in clarity and phrasing). The PROMIS PF
10 and 20 contain IRT-based items selected from the
PROMIS PF 154 item bank and include Item-Improved
HAQ and PF-10 items. The “IRT-based” PROMIS PF 10
and 20 are selected using IRT information content data
from over 21,000 subjects to identify the best items and
minor qualitative input to ensure that all major areas of
Physical Function/Disability were represented in the
instrument, with their strongest items. The PF 10 is a
subset of the best items in the PF 20.
For the analyses which follow, we scored all instru-
ments as the average of all items, either 10 or 20. All
instruments were scored on a 0 to 100 scale (100 =
worst disability) averaging scores of component items,
and reversing direction as appropriate. Participants also
completed validated pain and global health scales
[15,16]. The original Legacy instruments, HAQ and PF-
10, were administered and scored, then scores were
arithmetically adjusted to the 0 to 100 scale. Item-
Improved instruments were changed as appropriate
under PROMIS protocols for clarity, translatability with
focus groups, cognitive reviews, and cognitive surveys
including the patient perspective [10]. The item content
was unchanged from the Legacy instruments but the
time frame was moved to the present tense from “over
the past week” and the response options changed from
four to five by insertion of an option “with a little
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ceiling effects. The PROMIS 10 and 20 item instruments
included both Item-Improved old and new items from
the 154 item bank. All items contained the five response
options and present tense. The PROMIS 10-item set is
contained within the PROMIS 20-item set.
The PROMIS PF-10 instrument contains five original
HAQ derivatives and five original PF-10 derivatives
selected from the 30 items using IRT and content balan-
cing to include the better functioning items. The PRO-
MIS PF 20 instrument contains six items derived from
the HAQ, five from the PF-10, and nine new items from
the 124 items in the PROMIS physical function item
bank.
Items were selected for IRT information content after
consideration of content balancing issues by a study
group led by M. Rose. These methods were expected to
improve all of the original items to a greater or lesser
extent, and to improve the modified scales whenever a
new item with higher IRT scores replaced a Legacy
item.
Changes thus are considered evolutionary and to
remain buttressed by the hundreds of validation studies
that have been performed on the Legacy instruments
[1,2,10-12]. The primary objective was to show sensitiv-
ity of the new instruments to be equivalent (non-infer-
ior) to benchmark instruments. The secondary objective
was to explore areas where the new scales might actu-
ally be superior to the old (for example, normal or
severely impaired populations). Because of the small
effect sizes expected when comparing instruments rather
than interventions, statistical power may be marginal at
best. Computerized Adaptive Testing (CAT) applications
under evaluation currently utilize the entire 154-item
pool and should result in substantial further improve-
ment [8].
Implementation
We assessed participants using mailed questionnaires,
randomly ordering instruments within questionnaires to
eliminate order effects. We followed established Arthri-
tis Rheumatism and Aging Medical Information System
protocols for follow up and quality control [17].
Endpoints
The study endpoints were the 12-month change in
scores using each instrument, representing an average
progression of disability in rheumatoid arthritis over a
year. We studied the differences between instruments
rather than treatments; thus the effect-size is expected
to be much smaller than the effect of an RA treatment.
Observed change scores are a function of the “true
change” and of the error terms surrounding estimation
of the baseline and follow-up values. A more precise
instrument will have smaller standard errors, allowing a
more precise estimation of the true change. We used
the quantitative one-year change in Physical Function
scores under usual care; these changes include the pro-
gression of RA, the progression of co-morbid chronic
illness, and the progression of frailty related to aging.
Metrics
Responsiveness
We assessed participants’ 12-month Physical Function
change score from baseline and between instruments
(relative instrument sensitivity) with exact P-values
(pair-wise t-tests), computed Cohen’s[ 1 8 ]a n d
Guyatt’s [19] effect sizes (ES) (mean change from
baseline divided by baseline standard deviation (SD)
or change score SD), the standardized response mean
(SRM) (mean change score divided by SD of the
change) [19], and the minimum detectable difference
(MDD) [20].
Sample size
For between-instrument comparisons, we computed
sample sizes required per study arm for 80% power,
with an alpha of 0.05, given the delta that was observed.
We used bootstrapping methods to determine confi-
dence limits for the change score SDs and computed
the confidence limits for sample size requirements from
the confidence limits of the change score SD.
Statistics
Data are described by proportions and means (± SD).
We defined non-inferiority as when neither instrument
was statistically superior to the other at the P <0 . 0 5
level given 80% study power. Power for this study is
more than sufficient to detect a change equal to or
greater than the minimal clinically important difference
(MCID) for Physical Function, consistently cited for the
H A Qa t0 . 2 2u n i t so r7 %o ft h ep o s s i b l ec h a n g e[ 2 1 ] .
W eu s e dt h es a m e7 %o fp o s s i b l ec h a n g ee s t i m a t ef o r
each instrument since all were estimating the same
latent trait in the same subjects.
Since all instruments were scored identically and
resulted in similar change scores, the exact level of
MCID chosen is of only peripheral relevance. The mini-
mum detectible difference (MDD) is more directly rele-
vant to correlations between change scores of the six
instruments.
Results
Correlations between instruments were strong and all
changes were in the same direction and of similar mag-
nitude, indicating that all instruments are estimating the
same, or a similar, latent trait. Differences between
instruments are consistent with the SD of the change
score, which is smaller in the Item-Improved and IRT-
based scales.
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change scores, and significance levels. Pain (P = 0.31)
and global health scores (P = 0.02) were additionally
studied as reference domains. All instruments were
highly responsive to detection of change in function
over 12 months (P < 0.05), except for the pain scale.
With the Legacy and Item-Improved HAQ instru-
ments, there was little difference in scoring by aver-
aging eight categories versus 20 items, and we present
the average scores for all items for all instruments stu-
died to facilitate comparisons, as recommended by
PROMIS. [10] Standard deviations of the mean differ-
ence are substantially reduced with some instruments
as compared with others. These differences are
reflected in P-values but more importantly in the
metrics which follow.
Table 2 displays the SRM, ES, MDD, and sample size
requirements per study arm that are sufficient to detect
ac h a n g es c o r eo f2 . 5u n i t so na0t o1 0 0s c a l e .
Although the score progression ES over 12 months in
RA is small (0.05 to 0.06), all instruments were readily
able to detect this difference. Sample size requirements
vary widely, ranging from 95 to 427. The largest sample
sizes are for the Legacy and Improved PF-10. The Item-
Improved PF-10 reduced sample sizes by approximately
90, about one fourth, compared with its parent. The
Item-Improved HAQ reduces sa m p l es i z eb yo n e - t h i r d ,
compared with its parent. The PROMIS PF 20 and the
Item-Improved HAQ have similar sample size require-
ments in this population. Twenty-item scales outper-
form 10 item scales, item-improved scales outperform
their parent Legacy Forms, and five response options
outperform four.
Figure 1 shows study power as a function of the MDD
for four of the instruments. The more sensitive instru-
ments are best at detecting smaller differences. When
differences are large enough, there is little difference
between instruments.
Discussion
The fit between the severity distribution of the study
population and the range of coverage of the instrument
is centrally relevant to responsiveness, standard devia-
tion of change, and sample size requirement issues. An
instrument with items about eating, dressing, and
grooming will not be sensitive to change in a population
of college athletes since most will be able to do these
activities easily. An instrument with items based around
strenuous and difficult items about walking and climb-
ing stairs will not perform well in a population with
Table 1 Physical function instruments, baseline, 12-month, and change scores
Change Scores (12 months -
Baseline)
Items (n) Response options (n) Baseline mean ± SD
1 12-Months Mean ± SD Mean SD
(95% CL
2 for SD)
P-value
3
Legacy PF-10 10 3 47.2 ± 29 49.0 ± 29 1.8 18.4 (16.5, 20.2) 0.04
Legacy HAQ 20 4 29.2 ± 23 30.7 ± 24 1.5 10.6 (9.4, 11.8) 0.002
Item-Improved PF-10 10 5 41.5 ± 26 43.0 ± 27 1.5 16.3 (13.9, 18.6) 0.05
Item-Improved HAQ 20 5 21.0 ± 21 22.1 ± 21 1.1 8.6 (7.7, 9.6) 0.01
PROMIS PF 10 10 5 33.9 ± 22 35.2 ± 23 1.3 11.1 (10.0, 12.2) 0.01
PROMIS PF 20 20 5 30.6 ± 21 31.8 ± 22 1.2 9.4 (8.4, 10.1) 0.01
1 Standard Deviation,
2 Confidence Limits,
3 Pair-wise t-test.
HAQ, health assessment questionnaire; Item-Improved, Changes to items intended to improve their performance by altering parameters such as time frame and
response options while retaining the same item stem; PF, physical function; PROMIS, Patient-Reported Outcomes Measurement Information System.
Table 2 Physical function instruments, metric scores, and sample size requirements
Standardized response
mean
Cohen’s effect
size
Guyatt’s effect
size
Minimum detectable
difference
Sample size requirement n
(95% CL
1)
Legacy PF-10 0.10 0.06 0.49 2.43 427 (345, 514)
Legacy HAQ 0.14 0.06 0.52 1.40 143 (113, 176)
Item-Improved
PF-10
0.09 0.05 0.59 2.16 336 (245, 436)
Item-Improved
HAQ
0.13 0.05 0.73 1.14 95 (76, 117)
PROMIS PF 10 0.13 0.05 0.52 1.47 157 (127, 189)
PROMIS PF 20 0.13 0.05 0.63 1.24 113 (90, 141)
1 Confidence Limits
HAQ, health assessment questionnaire; Item-Improved, Changes to items intended to improve their performance by altering parameters such as time frame and
response options while retaining the same item stem; PF, physical function; PROMIS, Patient-Reported Outcomes Measurement Information System.
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categories.
To illustrate the role of floor and ceiling effects in
r e d u c i n gs t u d yp o w e r ,F i g u r e2s h o w sd a t af o ro v e r
18,000 PROMIS participants from these six instru-
ments, drawn from an approximately normal popula-
tion [10]; these are sometimes termed “boat diagrams”.
The horizontal axis represents different functional abil-
ities with zero representing the population mean, and
each unit to the left representing one SD below the
mean. Each unit to the right represents one SD above
the mean. The vertical axis represents the standard
error (instrument reliability), a sensitivity criterion,
shown with reference reliabilities of 0.90 and 0.95.
Instruments yield information curves that are more
informative at some physical impairment (theta) levels
than others. Above the population mean, all current
instrument curves rapidly lose their sensitivity and rise
steeply, representing a ceiling effect. Below the mean,
some curves lose power at about three SDs, while
others maintain sensitivity to beyond four SDs.
Depending on the severity distribution in a sample
sensitivity for a given instrument will be higher or
lower. Item-Improved and IRT-based observed instru-
ment improvement is largely due to better coverage of
areas of lesser impairment.
The Item-Improved HAQ outperforms the Item-
Improved PF-10 when functional abilities are more than
1.4 SD units below the population mean, while the
opposite is true when abilities are better (Figure 2). The
PROMIS PF 20 combines these attributes and has the
greatest sensitivity across the widest range of Physical
Function.
Item-improvement processes and use of IRT-based
items can lead to improved instrument performance. In
turn, this can make clinical research more efficient and
less costly by reducing required sample sizes. The
Legacy PF-10 is the most extensively used Physical
F u n c t i o ns c a l ea n di sav a l id benchmark for assessing
change. However, it is limited, having only 10 items and
0
0.2
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0.6
0.8
1
0.5 0.75 1 1.25 1.5 1.75 2 2.25 2.5 2.75
P
o
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e
r
Minimum Detectable Difference (%)
Legacy PF-10
Improved PF-10
Improved HAQ
PROMIS PF 20 
Figure 1 Power versus minimum detectable difference (MDD). Study power as a function of the MDD, computed as the percent difference
for four instruments in 451 RA patients. The Item-Improved HAQ and PROMIS PF 20 show greater power across most MDD levels. The Item-
Improved PF-10 is substantially more informative than the Legacy PF-10. The maximal power difference between the greater and lesser curves is
with an MDD of 1 to 1.5 percent; instruments behave more similarly when the MDD is larger or smaller. Instruments that are more sensitive
have their greatest advantages in detecting small differences; when differences are large, there is less difference between individual instruments.
HAQ, health assessment questionnaire; PF, physical function; PROMIS, Patient-Reported Outcomes Measurement Information System; RA,
rheumatoid arthritis.
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than 20-item scales or scales with five response options.
The Item-Improved HAQ performed essentially as
well as the PROMIS PF 20 in the RA patients studied.
This initially unexpected result was partly due to iden-
tical response options in the two instruments and to a
number of shared items. More importantly, however,
these RA patients had average disease severity one to
two SDs below the mean, where the HAQ is most sen-
sitive. Where the PROMIS PF 20 is strongest in com-
parison to the HAQ is in the one-half SD range near
the population mean (Figure 2), a population not
included here. The PROMIS PF 20, therefore, may be
expected to outperform the HAQ in such populations
[5,8,9].
The Item-Improved PF-10 outperformed the Item-
Improved HAQ in normal populations. Of historical
interest, the Legacy HAQ (perhaps not accidentally) has
generally been utilized for RA and other serious chronic
illness, and the PF-10 for more normal populations. The
IRT-based PROMIS PF 20, considering all levels of
impairment, outperforms the other instruments.
PROMIS and other CAT applications, better at esti-
mating function at the extremes, should provide sub-
stantial further improvement [8,9]. PROMIS is presently
investigating CAT applications. It appears likely that the
full potential of CAT applications requires calibration of
additional items at the floor and at the ceiling to further
improve the range of coverage. These items are pre-
sently being evaluated. Moreover, CAT requires electro-
nic administration in real time, and the logistics are
more cumbersome than with traditional pencil and
paper administrations.
Theoretically, a nearly equivalent result may be
obtained by using brief forms generated from the same
calibrated item bank and tailored for strong reliability in
a particular severity (theta) range matched to the study
population. Such brief forms may also be developed
through simulated CAT research, where the paths most
frequently chosen identify the best items [8,9].
Figure 2 Instrument sensitivity and disease severity. Physical Function, on the horizontal scale, is mapped against sensitivity (reliability) on
the vertical scale. A better scale has a greater breadth of Physical Function ability. The lower the curve, the greater the sensitivity. Across the
overall range, the PROMIS PF 20 is most sensitive, maintaining a reliability of 0.95 over more than four SD. The Item-Improved HAQ is superior to
the Item-Improved PF-10 in populations with function more than 1.2 SD from the mean (for example, Rheumatoid Arthritis) whereas the
opposite is true in populations with functional abilities better than this (for example, general population-based). HAQ: health assessment
questionnaire; Item-Improved: Changes to items intended to improve their performance by altering parameters such as time frame and response
options while retaining the same item stem; PF, physical function; PROMIS: Patient-Reported Outcomes Measurement Information System; SD,
standard deviation.
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[9]. PROMIS has defined the physical function domain
as “Physical Function” rather than “Disability”,e x p a n d -
ing the conceptual basis to both increments in ability
and decrements in ability. The predominant “gaps” in
the present PROMIS PF item bank are in “ceiling” activ-
ities above the population average and at the “floor”
represented by institutionalized populations. The more
immediate problem is the ceiling, where more than 20%
of these RA patients had zero HAQ scores. In healthy
aging studies, over 50% may be at this ceiling. This
results in a substantial loss of information and reduces
s t u d yp o w e r[ 2 2 ] .Y e t ,w em u s tb ea b l et oa s s e s sP h y s i -
cal Function above the mean to study normal or nearly
normal subjects where detection of improvement is pos-
sible only if the scale permits above average scores.
Additional advantages accrue to PROMIS instruments
that strengthen our confidence in recommending their
use. The PROMIS process [12], beginning with item
improvement, is directed at enabling instruments that
are more patient-centered, validly translatable, have bet-
ter clarity in diversely educated groups, have less Differ-
ential Item Functioning (DIF) across subgroups and are
focused on supporting efficiency in clinical research.
We, historically involved with the HAQ and PF-10, cur-
rently recommend the PROMIS PF 20 as the best avail-
able instrument for clinical studies with Physical
Function endpoints.
To our knowledge, this is the first randomized study
of alternative PRO instruments to document positive
results with IRT-based instruments over traditional
ones. We all are used to studies comparing treatments,
not instruments, where effect sizes are often 0.6 or
higher, rather than 0.06. This requires a different per-
spective, since improved PRO instruments are not inter-
ventions, but are more precise outcome measurement
tools, much like a more precise sedimentation rate or
more precise measurement of blood pressure. The
improved precision effect may be smaller than the Mini-
mally Clinically Important Differences (MCID) for inter-
ventions. They do, however, make it easier to detect
w h e t h e ra nM C I Di sp r e s e n to rn o t .T h i s ,i nt u r n ,
results in more efficient clinical research, requiring
fewer subjects, fewer centers, shorter recruitment peri-
ods, reduced time to study completion, and easier moni-
toring of the trial, all very important considerations.
Conclusions
The “present” of Physical Function assessment embodies
new instruments derived from improved items and
employing better item selection, which in turn results in
lowering sample size requirements and improving effi-
ciency. If 60 billion dollars is spent annually in the Uni-
ted States on clinical trial research and half of this (30
billion) is driven by per patient costs as opposed to
administrative costs, and if one-fourth of these (7.5 bil-
lion) use quality-of-life patient-reported outcomes (for
example, physical function, pain, fatigue, psychological
distress) as primary endpoints, and if sample size
requirements may be readily reduced by a factor of 2,
then the unnecessary costs for using larger than neces-
sary sample sizes may be in the range of three to eight
billion dollars in the United States annually [23,24].
The “future” will include items and instruments that
assess the floor and the ceiling and items and instru-
ments tailored to specific ranges of functional ability.
This will encourage broader functional status assessment
and will enable CAT instruments with even broader
coverage and greater precision of measurement.
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